Table of Contents

1 Study Coverage

• 1.1 Spine Biologics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Spine Biologics Market Size Growth Rate by Product
  • 1.4.2 Bone Graft
  • 1.4.3 Bone Graft Substitute
  • 1.4.4 Platelet Rich Plasma (PRP)
  • 1.4.5 BMAC (Bone Marrow Aspirate Concentrate)
• 1.5 Market by End User
  • 1.5.1 Global Spine Biologics Market Size Growth Rate by End User
  • 1.5.2 Anterior Cervical Discectomy and Fusion
  • 1.5.3 Posterior Lumbar Interbody Fusion
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Spine Biologics Market Size
  • 2.1.1 Global Spine Biologics Revenue 2014-2025
  • 2.1.2 Global Spine Biologics Sales 2014-2025
• 2.2 Spine Biologics Growth Rate by Regions
  • 2.2.1 Global Spine Biologics Sales by Regions
  • 2.2.2 Global Spine Biologics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Spine Biologics Sales by Manufacturers
  • 3.1.1 Spine Biologics Sales by Manufacturers
  • 3.1.2 Spine Biologics Sales Market Share by Manufacturers
  • 3.1.3 Global Spine Biologics Market Concentration Ratio (CR5 and HHI)
• 3.2 Spine Biologics Revenue by Manufacturers
  • 3.2.1 Spine Biologics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Spine Biologics Revenue Share by Manufacturers (2014-2019)
• 3.3 Spine Biologics Price by Manufacturers
• 3.4 Spine Biologics Manufacturing Base Distribution, Product Types
  • 3.4.1 Spine Biologics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Spine Biologics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Spine Biologics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Spine Biologics Sales by Product
• 4.2 Global Spine Biologics Revenue by Product
• 4.3 Spine Biologics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Spine Biologics Breakdown Data by End User

6 North America

• 6.1 North America Spine Biologics by Countries
  • 6.1.1 North America Spine Biologics Sales by Countries
  • 6.1.2 North America Spine Biologics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Spine Biologics by Product
• 6.3 North America Spine Biologics by End User

7 Europe

• 7.1 Europe Spine Biologics by Countries
  • 7.1.1 Europe Spine Biologics Sales by Countries
  • 7.1.2 Europe Spine Biologics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Spine Biologics by Product
• 7.3 Europe Spine Biologics by End User

8 Asia Pacific

• 8.1 Asia Pacific Spine Biologics by Countries
  • 8.1.1 Asia Pacific Spine Biologics Sales by Countries
  • 8.1.2 Asia Pacific Spine Biologics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Spine Biologics by Product
• 8.3 Asia Pacific Spine Biologics by End User

9 Central & South America

• 9.1 Central & South America Spine Biologics by Countries
  • 9.1.1 Central & South America Spine Biologics Sales by Countries
  • 9.1.2 Central & South America Spine Biologics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Spine Biologics by Product
• 9.3 Central & South America Spine Biologics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Spine Biologics by Countries
  • 10.1.1 Middle East and Africa Spine Biologics Sales by Countries
  • 10.1.2 Middle East and Africa Spine Biologics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Spine Biologics by Product
• 10.3 Middle East and Africa Spine Biologics by End User

11 Company Profiles

• 11.1 Medtronic
  • 11.1.1 Medtronic Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Medtronic Spine Biologics Products Offered
  • 11.1.5 Medtronic Recent Development
• 11.2 Depuy Synthes
  • 11.2.1 Depuy Synthes Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Depuy Synthes Spine Biologics Products Offered
  • 11.2.5 Depuy Synthes Recent Development
• 11.3 Stryker Corporation
  • 11.3.1 Stryker Corporation Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Stryker Corporation Spine Biologics Products Offered
  • 11.3.5 Stryker Corporation Recent Development
• 11.4 Nuvasive
  • 11.4.1 Nuvasive Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Nuvasive Spine Biologics Products Offered
  • 11.4.5 Nuvasive Recent Development
• 11.5 Zimmer Biomet
  • 11.5.1 Zimmer Biomet Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Zimmer Biomet Spine Biologics Products Offered
  • 11.5.5 Zimmer Biomet Recent Development
• 11.6 Orthofix International
  • 11.6.1 Orthofix International Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Orthofix International Spine Biologics Products Offered
  • 11.6.5 Orthofix International Recent Development
• 11.7 Globus Medical
  • 11.7.1 Globus Medical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Globus Medical Spine Biologics Products Offered
  • 11.7.5 Globus Medical Recent Development
• 11.8 alphatec spine
  • 11.8.1 alphatec spine Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 alphatec spine Spine Biologics Products Offered
  • 11.8.5 alphatec spine Recent Development
• 11.9 K2M
  • 11.9.1 K2M Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 K2M Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 K2M Spine Biologics Products Offered
  • 11.9.5 K2M Recent Development
• 11.10 Exactech
  • 11.10.1 Exactech Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Exactech Spine Biologics Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Exactech Spine Biologics Products Offered
  • 11.10.5 Exactech Recent Development
• 11.11 Wright Medical Technology
• 11.12 X-Spine
• 11.13 Nutech
• 11.14 Arthrex

12 Future Forecast

• 12.1 Spine Biologics Market Forecast by Regions
  • 12.1.1 Global Spine Biologics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Spine Biologics Revenue Forecast by Regions 2019-2025
• 12.2 Spine Biologics Market Forecast by Product
  • 12.2.1 Global Spine Biologics Sales Forecast by Product 2019-2025
  • 12.2.2 Global Spine Biologics Revenue Forecast by Product 2019-2025
• 12.3 Spine Biologics Market Forecast by End User
• 12.4 North America Spine Biologics Forecast
• 12.5 Europe Spine Biologics Forecast
• 12.6 Asia Pacific Spine Biologics Forecast
• 12.7 Central & South America Spine Biologics Forecast
• 12.8 Middle East and Africa Spine Biologics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Spine Biologics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.

The global Spine Biologics market is valued at 2060 million US$ in 2018 and will reach 2720 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Spine Biologics market based on company, product type, end user and key regions.

This report studies the global market size of Spine Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Spine Biologics in these regions.
This research report categorizes the global Spine Biologics market by top players/brands, region, type and end user. This report also studies the global Spine Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex

Market size by Product
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Market size by End User
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Spine Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Spine Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Spine Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Spine Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Spine Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Spine Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.